Neal D. Shore, Jayeta Chakrabarti, Sujata Narayanan, Stella Lin, Michael Thomas Schweizer. "Mevrometostat in combination with enzalutamide for androgen receptor pathway inhibitor (ARPI)-naïve patients with metastatic castration-resistant prostate cancer (mCRPC): The phase 3, randomized MEVPRO-2 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps5116